PMID: 6540415Sep 1, 1984Paper

Treatment of seizures with medroxyprogesterone acetate: preliminary report

Neurology
R H MattsonB C Siconolfi

Abstract

Medroxyprogesterone acetate (MPA), a synthetic progesterone, was added to the antiepileptic drug regimen of 14 women who had uncontrolled seizures. Of the 11 women who developed amenorrhea, 7 reported fewer seizures during MPA therapy. Overall reductions in seizure frequency averaged 30% (n = 11), declining from a baseline 8.3 +/- 5.8 seizures per month to 5.1 +/- 4.1 seizures per month (p = 0.02). No serious side effects were encountered, but spotting was common. These preliminary data suggest further evaluation of MPA for catamenial seizures.

Citations

Jan 1, 1989·Molecular Neurobiology·M Schumacher, B S McEwen
Apr 1, 2011·Current Neurology and Neuroscience Reports·Scott J Stevens, Cynthia L Harden
Sep 1, 1996·Obstetrics and Gynecology·J A Cramer
May 1, 1993·Pharmacology, Biochemistry, and Behavior·J W McAuleyI J Reynolds
Mar 1, 1989·Epilepsy Research·U BonuccelliA Muratorio
May 1, 1993·Epilepsy Research·G K HerkesT Moyer
Jun 1, 1992·Seizure : the Journal of the British Epilepsy Association·R A GrünewaldC P Panayiotopoulos
Jul 23, 2013·Brain Research·Eric R DeutschDavid W Wright
Apr 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Andrew G Herzog
Oct 7, 2003·Epilepsy & Behavior : E&B·Alexis Boro, Sheryl Haut
Nov 10, 1998·Contraception·R T Burkman, L P Shulman
Sep 24, 1999·Pediatric Clinics of North America·Z Harel, B Cromer
May 19, 2001·Neurologic Clinics·N Foldvary
Jul 10, 1998·Epilepsy Research·S MohammadM H Pourgholami
Apr 1, 2000·Journal of Pediatric and Adolescent Gynecology·V K Logsdon-Pokorny
Feb 24, 2001·Clinical Obstetrics and Gynecology·A M Kaunitz
May 12, 2006·The Neurologist·Victor W Henderson
Sep 22, 2007·Current Opinion in Obstetrics & Gynecology·Lama L Tolaymat, Andrew M Kaunitz
Nov 1, 1993·The Australian & New Zealand Journal of Obstetrics & Gynaecology·M Hayes, J Dunne
Jan 1, 1985·Epilepsia·R H Mattson, J A Cramer
Mar 1, 1988·Epilepsia·N KumarB L Jailkhani
Jan 1, 1991·Epilepsia·J A Cramer, E E Jones
Jan 1, 1992·Epilepsia·M J Morrell
Jan 23, 1999·Epilepsia·P Klein, A G Herzog
Jun 1, 2010·Continuum : Lifelong Learning in Neurology·Katherine H Noe, Alison M Pack
Jun 7, 2013·Continuum : Lifelong Learning in Neurology·Page B Pennell
Jun 1, 2012·Neurology·A G HerzogUNKNOWN Progesterone Trial Study Group
Oct 17, 2012·International Journal of Women's Health·Alberto VerrottiPiero Pavone
Jul 10, 2002·Clinical Pharmacokinetics·James W McAuley, Gail D Anderson
Aug 1, 2014·Drugs & Aging·Olafur Sveinsson, Torbjörn Tomson
Aug 12, 2014·Current Opinion in Obstetrics & Gynecology·Anna Lea Altshuler, Paula J Adams Hillard
Sep 17, 2014·Neurobiology of Disease·Barbara S Koppel, Cynthia L Harden
Mar 1, 2007·Women's Health·Doodipala S Reddy
Sep 2, 2008·Obstetrics and Gynecology·Paul D Blumenthal, Alison Edelman
Mar 8, 2007·Expert Review of Neurotherapeutics·Line Sveberg Røste, Erik Taubøll
Jul 2, 2005·Expert Opinion on Investigational Drugs·P Klein, A Herzog

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.